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Purpose: Diabetes type 2 is associated with a risk of at least 2 times higher for coronary heart disease. This study aims to 
determine the prevalence of coronary heart disease as well that of Risc Framingham Score to diabetic population and that of the 
control group (non-diabetic).  Methods: The study is of retrospective type, data were gathered in the Endocrinology in specialty 
polyclinic service no. 3 in Tirana. Patients were classified in diabetic patients with and without coronary events, as well as the 
control group. Data were collected for all coronary risk factors and the results were compared. Results: 500 patients were analyzed 
as diabetics: 23.8% of them reported coronary events, while only 3.2% of the control group reported coronary events. FRS for 
diabetic population showed 30 ± 15% vs. 15 ± 10% of the control group. Without angina Acute Myocardial infarctions were more 
frequent among women, while IM among men Conclusions: The high prevalence of coronary heart disease to the diabetic 
population compared to the control group; and high risk according to the Framingham for coronaropathy in the next 10 years, 
proving that diabetes is a major risk factor in coronary artery disease. 
 
 
 Introduction 
 For diabetes, as well as for other chronic pathologies it is already spoken for a real pandemy. In fact, 
diabetes is now widely distributed throughout the world and its incidence and prevalence are destined to grow 
with the progressive aging of the population and the globalization of unhealthy food habits.
i
. 
 Diabetes is presented in its two main forms: type 1 diabetes, also known as insulin dependents, that is 
characteristic of patients with early age and brings patients to the need  for insulin treatment; and type 2 diabetes 
that in prevalent way occurs after age 40 and does not require obligatory treatment with insulin. This form 
represents more than 90% of cases with diabetes. 
 Diabetes is a particularly difficult disease, above all due to numerous micro and macrovascular 
complications in patients who experience it. Diabetic macroangiopathy complications constitute diabetic 
retinopathy which represents the biggest cause of blindness in adults, and diabetic nephropathy, which can lead 
to chronic renal failure and dialysis and diabetic neuropathies. 
 In North America type 2 diabetes is associated with almost twice the risk of occurrence of artero-
coronary diseases. The prevalence of coronary disease in artero-adult diabetics is about 45% compared to 25% 
in individuals without diabetes. A recent survey has confirmed a prevalence of coronary artero-disease with 
51%. 
 However, this figure appears to be lower in European countries. In 1985, a study conducted by the 
World Health Organization on vascular disease in diabetics reported a prevalence of coronary artery disease by 
about 30% in males and females. Recent studies from England and France estimate CES prevalence by 25% and 
18% respectively.  
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 In general, previous studies report dramatic changes in the prevalence of CES in diabetic patients 
compared with those non-diabetics (Ann Intern Med 1996, 124: 136-145). 
 The low prevalence of large vessel disease in Europe may be associated with a better control of diabetes 
as shown in the study UKPSD. In Italy, almost 70% of diabetic patients are followed at least once a year by 
specialized centers enabling them an ease for an extensive epidemiological studies.
ii,iii
. 
 This study reports data on the prevalence of coronary artery disease among diabetic patients in Albania. 
 Aims of the study 
 
 Aims of the study are: 
  1. To determine the prevalence of diabetic patients who do coronary artery disease in relation to non-
diabetic population 
  2. To compare the risk assessment of coronary heart disease (SCORE) in diabetic patients versus the 
control group. 
 3. Assess risk factors among diabetic patients with coronary episodes and those without coronary 
episodes. 
  4. To show the differences between the prevalence of coronary disease among male and female 
population received in the study. 
 Materials and methods 
 The retrospective study was conducted on type of Endocrinology service in Tirana's central polyclinic 
and in patients with diabetes  in the American Hospital 2 Tirana. In the study were included 500 diabetic patients 
of type 2after the approval was taken for inclusion in the study. 
 These patients underwent questionnaire to assess risk factors of coronary disease and were observed 
changes in values of laboratory analysis throughout the study. SAK is diagnosed by specialist cardiologists 
based on the results of the ECG and coronarographies. 
 The control group consists of 500 random non-diabetic  patients taken from daily visits to the health 
center no. 4 in Tirana. 
 All data presented in this study refer to the population of patients in the study received. 
 Results 
 In the study, 500 patients participated. The average age of participants was 64 ± 11 to ± 11 males and 67 
for females. Ratio male / female is 243/257 respectively, or expressed in percentage 48.6% male and 51.4% 
female. Average age of diabetes is higher among women than men (10:49 ± 9:19 to 8:57 ± 7.78 females and 
males). 
 Diabetic patients  
(n=500) 
Control group 
(n=500) 
  Value p 
Coronary diseases     23.8 % (119)  3.2 % (16) < 0.0001 
Prevalence of coronaropathies to diabetic and non-diabetic population 
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Graph 1  
 
 
The prevalence of coronary disease in diabetic patients and control group 
Graph 2 & 3  
Graphic distribution of coronary events in males patients with diabetes (above) and females (below). Data on the 
axis ordinates are expressed in percentage. 
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Graph 4 
Characteristics of the diabetic males population who have developed diabetes and who have not developed 
episodes of coronary artery disease. 
 
Graph 5 
Changes in plasma glucose levels between diabetic patients with coronaropathy and those without 
coronaropathy. 
 
Graph 6 
The percentage of diabetic patients with higher HbA1c than the maximum limit 
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Table 1 
 
Values of the risk to develop coronaropathy within the next 10 years. 
The risk of coronary 
phenomena 
Diabetic females 
(n=257) 
Non-diabetic females 
(n=238) 
Value p 
Minimal risk (%) 14  8 < 0.001 
Maximal risk (%)  >27 13 <0.001 
 
 
Graph 7 
 
Distribution of risk for coronaropathy to the diabetic females population and control group. 
 
 
Table 2 
  
 Values of the risk in percentage to develop coronaropathy within the next 10 years (calculated 
according to the Framingham) 
The risk of coronary 
phenomena 
Diabetic males 
(n=257) 
Males of control group. 
(n=238) 
Value p 
Minimal risk (%) 13 5 < 0.001 
Maximal risk (%)       45 25 <0.001 
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Graph 8 
Coronaropathy risk distribution of males diabetic population and control group. 
 
  
 Discussions 
 This study was conducted with patients enrolled and followed in the Endocrinology Service at the 
central specialties polyclinic of Tirana, in collaboration with the health center no. 4 in Tirana, measured the 
prevalence of coronary disease in a group of 500 patients with diabetes. In addition, the prevalence was 
measured at 500 coronary patients of the control group, who did not suffer from Diabetes Mellitus. 
 Both these measured values were compared and it was observed that the prevalence of coronary disease 
in diabetics was significantly higher than the non-diabetic population. It appeared that this prevalence was 
23.8% among diabetic population, compared with 3.2% of the control group. Value reported in studies 
conducted in Italy by DAI group shows a prevalence of about 16.7% (performed last year), a figure which is 
lower than in other European countries (Diabetes Med 2000; 17: 146 - 151)
iv
; ; this is explained by a better 
oversight, as well as a health education of better diabetics performed in Italy, as well as the lifestyle where the 
Mediterranean diet iscombined with regular delivery of physical activity.
v
. 
 Group of male diabetic patients who have developed coronaropathy has a higher average age (p 
<0.0001), has an average seniority of diabetes 11.5 ± 7.8, which is significantly higher than the group of diabetic 
patients who did not develop pathology of coronary artery (with an average seniority 6:42 ± 10, p <0:05). 
 It is observed statistically significant difference in plasma glucose variable (p <0.0001), and percentage 
of population with HbA1c> 7 mg, which is reported a high percentage of diabetic population compared with 
coronaropathy events compared  with thoshe that did not develop these events (p = 0.002). Calculation of risk 
for coronary disease was carried by FRS (Framingham score Circulation 117 (6): 743-753.)
vi,vii
. Thus shown that 
for diabetic women, the risk for developing coronaropathy within the next 10 years ranges from 14% to over 
27% (for those diabetic women with high levels of triglycerides and low HDL value-cholesterol). While the risk 
to the control group ranges from 8-13% for those with higher indices of risk variables (p <0.001). 
 This difference was deemed statistically significant, which confirms our hypothesis that diabetes is a 
risk factor for coronary disease. 
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 It was observed that with diabetic males the risk for developing coronary events within the next 10 
years ranged from 13 to 45% while with the males of control group the risk for developing coronary events 
ranged from 5% -25% (p <0.001). 
 As noted, the percentage of risk for coronaropathy in the control group reaches a maximum figure of 
25% (which makes it to be considered as a high risk for coronaropathy), this is because a significant variable in 
predicting cardiovascular risk (mainly diseases of coronary arteries) according to Framingham is age, where it 
was highlighted that older women as a result of the development of menopause, dislipidemies and hypertension, 
had a higher prevalence of coronary artery disease. Because this control group results in an average age 61 ± 11 
years, the risk of developing coronaropathy in the next 10 years remains high for the age factor, although these 
patients are not diabetic. 
 Based on the graphs described in section 2.4.2 was concluded that diabetic population that has not yet 
developed coronaropathy, there is a risk that varies from 13 to 45% of the population of diabetic males, 
compared with 5-25% of group control, where the band calculation is made based on the minimum and 
maximum values of the data obtained from patients in the study. 
 
 Thus, 13% risk of diabetic patients corresponds to those who have a less altered lipidic profile, and 
better equilibrium of plasma glucose; while 45% of risk matches to those patients who have a poor monitoring 
of plasma glucose and glycated hemoglobin. We see also that for the population of diabetic males are compared 
with 5-25% of the control group. 
 
 However, the same is true for diabetic patients, and comparing the results of both groups it is evidenced 
a risk almost three times higher for diabetics to develop coronaropathy compared with the control group. P value 
indicates that the result is statistically significant, which confirms our hypothesis. So, it is evidenced a much 
expressed riskier for coronaropathy over a period of 10 years with diabetic population versus the control group. 
 Conclusion  
 
 First, it was determined the prevalence of coronary diseases in patients with diabetes compared with 
non-diabetic population, and resulted that patients with diabetes mellitus have a prevalence of 23.8% for 
developed coronaropathy, compared with 3.2% of the normal population, which is about 7 times higher 
compared with the control group. Pathologies of coronary events were more frequent in males than diabetic 
females. 
 
 Another important conclusion of this study is the determination of the risk factors for coronary artery 
disease within the diabetic population. Thus, by the results presented, it was concluded that diabetic males and 
females who have developed coronaropathy, have a significant average seniority and higher diabetes compared 
with diabetics who did not develop coronaropathy. Likewise, they present an unbalanced condition of diabetes, 
with an average value of high plasma glucose as well as a higher leve of glocosated hemoglobin than its 
maximum limit. It can be said that the age of diabetes, its state of equilibrium, as well as values of glukosated  
hemoglobin were statistically significant risk factors for coronary artery disease. 
 Because diabetes is a pathology which does not only alters carbohydrate metabolism but also of fat, it 
was observed that older diabetic patients with improper monitoring of plasma glucose reported altered values of 
lipidograma (diabetic dyslipidemia), which in itself constitute a major risk factor for coronary artery disease. 
 Page | 169  
Anglisticum Journal (IJLLIS), Volume: 3 | Issue: 6 |  
 
  June 2014  e-ISSN: 1857-8187   p-ISSN: 1857-8179                                                                                             Research paper 
 Thus, valuable conclusion of this study is that not good monitoring of diabetes results in an alteration of 
lipid profile by increasing the risk for coronary pathology. Another objective of this study was the prediction of 
risk for developing coronaropathy within the next 10 years, according to Framingham SCORE in the diabetic 
population and the control group. So, it is observed that the risk of FRS is about 2-3 times higher in diabetic 
patients compared with the control group which confirms our hypothesis that diabetes is a major risk factor in 
the development of macrovascular complications such as coronary artery disease, which has once been the main 
focus of this paper. 
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